Should a statin be given to all hypertensive patients?
Statins have become an essential treatment for primary and secondary prevention of cardiovascular risk. This has been firmly established for patients with a relatively high risk for cardiovascular complications. Recent studies, in particular the HOPE trial, has extended this observation to patients...
Main Author: | Harry Struijker-Boudier |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Artery Research |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125924985/view |
Similar Items
-
Statins associated diabetes: state of the problem in 2018
by: Zh. D. Kobalava, et al.
Published: (2018-09-01) -
Patient-Reported Reasons for Not Using Primary Prevention Statin Therapy
by: Cassandra M. DeWitt, et al.
Published: (2020-10-01) -
Are statins beneficial for the treatment of pulmonary hypertension?
by: Lei Wang, et al.
Published: (2017-12-01) -
RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01) -
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice
by: Giosiana Bosco, et al.
Published: (2023-03-01)